8 - 10 Most literature focuses on 30-day adverse events, but the occurrence of these outcomes has been shown to still be quite significant beyond the early post-operative period, with studies showing 90-day readmission rates at 19% and mortality rates rising from 13.3% at 1 month to 15.8% in 3 to 6 months. 12 , 13 Research has gone on to identify predictors for these adverse events, and exacerbation of active comorbid conditions is kn
← all excerpts
Higher Charlson Comorbidity Index Increases 90-Day Readmission Rate with Poorer Functional Outcomes in Surgically Treated Hip Fracture Patients.
1
—
—